Natco Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524816	NSE Symbol:	NATCOPHARM	P/E :	9.79
ISIN Demat:	INE987B01026	Div & Yield %:	0.59	EPS :	103.31
Book Value:	409.46	Market Cap (Rs. Cr.):	18,106.22	Face Value :	2

Date	Headline
13-Jun-25	Natco Pharma's Mekaguda API unit completes USFDA inspection
13-May-25	Natco Pharma to conduct board meeting
08-Apr-25	Natco Pharma update on launch of Risdiplam in India
12-Feb-25	Board of Natco Pharma recommends Third Interim Dividend
10-Feb-25	Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
31-Jan-25	Natco Pharma to hold board meeting
30-Jan-25	Natco Pharma receives approval for its ANDA for Everolimus tablets for oral suspension
21-Nov-24	Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution
12-Nov-24	Natco Pharma fixes record date for 2nd interim dividend
29-Oct-24	Natco Pharma to announce Quarterly Result

Company Snapshot